The estimated Net Worth of Laurent Paulhac is at least $2.66 Million dollars as of 14 September 2012. Laurent Paulhac owns over 3,585 units of CME Inc stock worth over $2,442,743 and over the last 15 years Laurent sold CME stock worth over $214,060.
Laurent has made over 1 trades of the CME Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Laurent sold 3,585 units of CME stock worth $214,060 on 14 September 2012.
The largest trade Laurent's ever made was selling 3,585 units of CME Inc stock on 14 September 2012 worth over $214,060. On average, Laurent trades about 512 units every 0 days since 2009. As of 14 September 2012 Laurent still owns at least 11,175 units of CME Inc stock.
You can see the complete history of Laurent Paulhac stock trades at the bottom of the page.
Over the last 21 years, insiders at CME Inc have traded over $264,111,034 worth of CME Inc stock and bought 77,667 units worth $15,169,350 . The most active insiders traders include Terrence A Duffy, Phupinder Gill und Bryan T Durkin. On average, CME Inc executives and independent directors trade stock every 10 days with the average trade being worth of $863,868. The most recent stock trade was executed by Bryan T Durkin on 30 August 2024, trading 7,593 units of CME stock currently worth $1,629,382.
as the world's leading and most diverse derivatives marketplace, cme group (www.cmegroup.com) is where the world comes to manage risk. cme group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. cme group brings buyers and sellers together through its cme globex® electronic trading platform and its trading facilities in new york and chicago. cme group also operates cme clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through cme clearport®. these products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.
CME Inc executives and other stock owners filed with the SEC include: